There is one central fact to which I owe my career, as do many of us in this room: that is the wondrous and mysterious fact that magnetic resonance never seems to be done.
"There is one central fact to which I owe my career, as do many of us in this room: that is the wondrous and mysterious fact that magnetic resonance never seems to be done. No matter how much we think we know, no matter how much we are convinced we are converging toward consensus, there is always something new lurking in the shadows.
"As we all know, MR operates on one of nature's simplest quantum mechanical systems: a two-state system in its most basic guise. But somehow, this rudimentary system not only manages to suffer all the indignities we think to impose on it-SMASH, FLASH, STEAM, BLAST, BURST-but also offers up time and again new information to enlighten us and aid our patients.
"In the words of one of my favorite obscure wordsmiths, Samuel Bowditch, 'There is in this earth no maneuver more unnerving than the spin. Just when one thinks to have advanced into the twilight, dawn comes around again.'"
-Dr. Daniel K. Sodickson, an assistant professor of radiology, accepting the Gold Medal award of the International Society for Magnetic Resonance in Medicine at the society's 2006 meeting in Seattle.
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
Diffusion-Weighted MRI and Neoadjuvant Chemotherapy for Rectal Cancer: What New Research Reveals
September 3rd 2024In a comparison of imaging assessments to gauge the effectiveness of neoadjuvant chemotherapy for rectal adenocarcinoma, researchers found the combination of diffusion-weighted imaging and MR tumor regression grading had a 90 percent area under the curve (AUC) and a negative predictive value (NPV) of 93 percent.
FDA Expands Clearance of MRI-Guided AI Platform for Deep Brain Stimulation and Lesioning Techniques
September 3rd 2024Utilizing a new machine learning model, the OptimMRI software may improve radiosurgery applications and lesioning techniques such as MRI-guided focused ultrasound through enhanced targeting of the inferolateral part of the ventral intermediate nucleus (VIM).